Position in DCTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,683,135
-$3,252,412 QoQ
Shares Held
289,131
-50.8% QoQ
Ownership
0.838%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DCTH Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $6,785,897,738 across 94 Medical Devices names. DCTH ranks #58 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
14,505,201 | $1,489,248,984 | |
| 2 | BSX |
Boston Scientific Corp
|
18,891,624 | $1,185,449,403 | |
| 3 | SYK |
Stryker Corp
|
2,669,835 | $877,281,079 | |
| 4 | MDT |
Medtronic plc
|
5,600,590 | $485,291,119 | |
| 5 | EW |
Edwards Lifesciences Corp
|
5,082,050 | $406,970,562 | |
| 6 | PEN |
Penumbra Inc
|
720,575 | $236,615,212 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,266,138 | $232,483,701 | |
| 8 | DXCM |
Dexcom Inc
|
3,043,635 | $191,140,276 |
All Filings in DCTH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,683,135 | 289,131 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,935,547 | 587,678 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,925,021 | 272,095 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,088,333 | 153,554 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,571,989 | 123,487 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $936,615 | 77,792 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $181,123 | 20,058 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $326,948 | 39,062 | Shares | Defined | 2024-08-13 | |
| 2021-03-31 | $125,404 | 10,097 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||